Metabio bridges the technical gap in the biobank sector, bringing together patients, healthcare providers, biobanks and researchers. Metabio technology harmonises and collects pre-analytics, and provides additional revenue streams for biobanks, while it reduces the cost and time of drug development cycles during the crucial preclinical research stage. The e-MetaBio platform offers interoperability and standardisation when collecting data relating to the patient and the human biological sample, using digital access rights management processes, in real-time, establishing digital consent for accessing and transferring data in the biological sample usage chain. The e-MetaBio platform connects all members of the biological sample usage chain, creating added value, and collects EHRs from hospitals, real-world data from patients, research outcomes and data relating to biological samples. Metabio technology makes it possible to search for biological samples and patient profiles in real-time, reducing costs and democratising biological sample donations.